Results 31 to 40 of about 690,085 (165)

Real‐World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry

United European Gastroenterology Journal, Volume 14, Issue 4, May 2026.
ABSTRACT Background Upadacitinib (UPA) is the first oral Janus kinase (JAK) inhibitor approved for the treatment of Crohn's disease (CD). Real‐world data, particularly from large nationwide cohorts, remain limited. This study aimed to evaluate the real‐world effectiveness, safety, and treatment persistence of UPA in patients with CD.
M. Iborra, B. Botella, M. D. Martín‐Arranz, D. Ceballos, C. Martínez‐Pascual, A. Garrido, P. Varela, M. Moreta, E. Brunet‐Mas, Y. González‐Lama, E. Rodríguez‐González, M. Vicuña, J. P. Gisbert, I. Ordás, F. Argüelles‐Arias, J. Tosca‐Cuquerella, R. Vicente‐Lidón, M. Sierra‐Ausín, I. Rodríguez‐Lago, D. Martín‐Rodríguez, J. M. Paredes, B. Sicilia, I. García de la Filia, N. Jiménez, M. Barreiro‐de Acosta, E. Betoré, I. Ferrer‐Bradley, L. García‐Alles, J. M. Huguet, S. Castellet‐Farrús, M. J. García, A. Gutiérrez‐Casbas, Á. Ponferrada‐Díaz, L. Ramos, M. Calafat, I. Vera, C. Suárez‐Ferrer, E. Fernández‐Velado, S. Rodríguez‐Sánchez, A. Mínguez, A. Mancebo, J. Barrio, S. Lario, D. R. de La Cruz, Alejandro Hernández‐Camba, C. Rodríguez‐Gutiérrez, M. Chaparro, E. Ricart, L. Almenara‐Michelena, A. Balaguer, E. Domènech, P. Nos   +51 more
wiley   +1 more source

Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation

Revista de Gastroenterología de México (English Edition), 2017
The incidence and prevalence of inflammatory bowel disease (IBD) has increased in recent years in several Latin American countries. There is a need to raise awareness in gastroenterologists and the population in general, so that early diagnosis and ...
J.K. Yamamoto-Furusho, F. Bosques-Padilla, J. de-Paula, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.L. Rocha, F. Steinwurz, G. Veitia, C. Zaltman   +10 more
doaj   +1 more source

Inflammatory bowel disease in Mexico: Epidemiology, burden of disease, and treatment trends

Revista de Gastroenterología de México (English Edition), 2020
Introduction and aims: There is no systematized information for determining/monitoring the burden of inflammatory bowel disease in Mexico. The aim of the present study was to estimate the annual burden of inflammatory bowel disease on the Mexican ...
J.K. Yamamoto-Furusho, F.J. Bosques-Padilla, L. Charúa-Guindic, T. Cortés-Espinosa, R.M. Miranda-Cordero, A. Saez, Y. Ledesma-Osorio   +6 more
doaj   +1 more source

Consenso latinoamericano acerca de indicadores de calidad para Clínicas de Atención Integral para pacientes con enfermedad inflamatoria intestinal: PANCCO-GETECCU

Revista de Gastroenterología de México, 2022
Resumen: Introducción: La enfermedad inflamatoria intestinal (EII) es una entidad crónica e incurable. La Pan American Crohn's and Colitis Organisation (PANCCO) tiene como objetivo generar concientización sobre la EII, con especial énfasis en ...
J.K. Yamamoto-Furusho, D. Andrade, J. Barahona, S. Bautista, F. Bosques-Padilla, J. de Paula, M.T. Galiano, B. Iade, F. Juliao-Baños, G. Otoya, F. Steinwurz, E. Torres, G. Veitia, M. Barreiro-de Acosta   +13 more
doaj   +1 more source

Barriers Associated With Treatment Nonadherence in Mexican Patients With Ulcerative Colitis: The Role of Medication Beliefs

Journal of Clinical Pharmacy and Therapeutics, Volume 2026, Issue 1, 2026.
Background The adherence to medical treatment is important in patients with inflammatory bowel disease (IBD) in order to maintain remission and avoid complications. The aim of this study was to identify the demographics, clinical features, and patients’ barriers associated with nonadherence to medical treatment in Mexican patients with ulcerative ...
Ana Fresán, Karen A. Yamamoto-Rodríguez, Katia M. Yamamoto-Rodríguez, Jesus K. Yamamoto-Furusho, Anjali Chauhan   +4 more
wiley   +1 more source

The Mexican consensus on the diagnosis and treatment of ulcerative colitis

Revista de Gastroenterología de México (English Edition), 2018
The guidelines presented herein are an updated version of the recommendations published in 2007. Since then, there has been a rapid advance in the knowledge about the pathophysiology of ulcerative colitis and its therapeutic options.
J.K. Yamamoto-Furusho, Y. Gutiérrez-Grobe, J.G. López-Gómez, F. Bosques-Padilla, J.L. Rocha-Ramírez   +4 more
doaj   +1 more source

Guía de endoscopia en enfermedad inflamatoria intestinal

Endoscopia, 2021
En México la incidencia de la enfermedad inflamatoria intestinal ha incrementado. Esto hace que el especialista tenga mayor conocimiento de las herramientas diagnósticas disponibles, terapias farmacológicas y seguimiento de la enfermedad, lo que impacta ...
Jony Cerna-Cardona, Mario Peláez-Luna, Gretel B. Casillas-Guzmán, Xochiquétzal Sánchez-Chávez, Azucena I. Casanova-Lara, Héctor Espino-Cortés, Andrés S. Hernández-Ángeles, Eumir I. Juárez-Valdés, María Elena López-Acosta, Jesús G. López-Gómez, Clara L. Martínez-García, Alejandra Noble-Lugo, Ángel A. Reyes-Dorantes, Moisés Salamanca, Omar E. Trujillo-Benavides, Ylse Gutiérrez-Grobe, Luis Eduardo Zamora-Nava, Patricio C. Acosta Rodríguez-Bueno, Miguel Á. Herrera-Servin, Justo A. Fernández-Rivero   +19 more
doaj   +1 more source

Fungal‐Bacterial Dysbiosis in IBD: Microbial Biomarkers of Disease Activity

MicrobiologyOpen, Volume 14, Issue 6, December 2025.
This study characterizes bacterial, fungal, and viral communities in Crohn's disease and ulcerative colitis using intestinal and faecal samples. Distinct microbial signatures and inter‐kingdom interactions were identified, with taxa such as Prevotella, Fusobacterium, and Roseburia linked to disease activity.
Elisa Arribas‐Rodríguez, María García‐Pizarro, Ángel De Prado, María Santiago‐Carretero, Marta Hernández, Benito Velayos Jiménez, Javier García‐Alonso, Jesús Barrio, José María Eiros, Eduardo Arranz, David Bernardo, Luis Fernández‐Salazar, Sara Cuesta‐Sancho   +12 more
wiley   +1 more source

Nutrición y enfermedad inflamatoria intestinal [PDF]

, 2007
En este artículo se revisan las causas y consecuencias de los déficits nutricionales en la enfermedad inflamatoria intestinal, con especial énfasis en sus implicaciones fisiopatológicas.
Cabré Gelada,E.
core   +1 more source

Serie de casos de un nuevo fenotipo (CUCrohn) de la enfermedad inflamatoria intestinal en pacientes mexicanos

Revista de Gastroenterología de México
Resumen: Recientemente se describió un nuevo fenotipo de la enfermedad inflamatoria intestinal denominada UC2CD (por sus siglas en inglés), caracterizada por la transformación de la colitis ulcerosa crónica idiopática hacia el fenotipo de la enfermedad ...
J.K. Yamamoto-Furusho, F.D. Gutiérrez-Herrera, I.E. Bravo-Espinoza, I.P. Padilla-Betancourt   +3 more
doaj   +1 more source